31 Clinical, Medical & Diagnostic Products
New CE-IVD NGS Test and Analysis Software for Use in Clinical Labs
CRYOGEN: Liquid Nitrogen Generator for Laboratories and Medical Applications
Liquid Nitrogen (LN2) is commonly used for a variety of applications across a wide range of industry sec- tors, including IVF (storage of samples), food pack- aging, cryotherapy, dermatology, lab applications and metal treatment to name just a few. In most cases, customers are reliant on deliveries of liquid nitrogen in the form of cylinders or Dewars, which gives rise to a number of pain points. It could be that you’re paying
too much for LN2, with prices subject to fl uctuation and controlled by your gas supplier.
Offering up to 240L/day, CRYOGEN from F-DGSi is a range of stand-alone LN2 generators. With CRYOGEN, there is no need for regular refi lling or dependence
Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumour molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, lengthy turnaround times can limit the clinical utility of these results. To meet the need for rapid genomic insights, Thermo Fisher Scientific has launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.
Using targeted NGS technology, the Oncomine Dx Express Test delivers clinically relevant tumour mutation profiling in as little as 24 hours to aid healthcare professionals, in accordance with professional guidelines, in therapy management of cancer patients. The qualitative in vitro diagnostic (IVD) test detects deletions, insertions, substitutions and copy number gain present in 42 genes and fusions or splicing variants in 18 genes from DNA and RNA in FFPE tumour tissue samples of solid malignant neoplasms. This assay also detects deletions, insertions, substitutions in 42 genes and fusions or splicing variants in seven genes from cfTNA extracted from plasma samples of non-small cell lung cancer (NSCLC). The assay requires minimal sample input, maximising sample success rates.
The Oncomine Reporter Dx software ensures healthcare providers can quickly assess the genomic test results. The software matches the variant data to relevant evidence including approved therapies, guidelines, clinical trials and peer reviewed literature in a user-friendly and customisable report.
The new NGS assay and genomic reporting software, along with the recently launched Ion Torrent Genexus Dx Integrated Sequencer, offer an automated end-to-end CE-IVD workflow. Operated from a single software interface, the overall process includes less than 20 minutes of hands-on time, delivering results with unprecedented rapid turnaround time. The workflow enables any lab to bring the power of genomic testing in-house, improves access to patients and advances precision oncology for those who stand to benefit most.
More information online:
ilmt.co/PL/PxzP 58740pr@reply-direct.com
on your LN2 vendor. No bulk storage is required, and installation can be confi ned to compact space in
your premises. CRYOGEN enables you to take back
control of LN2 production and eliminate some of the headaches associated with traditional methods of delivery. Moreover, you can achieve an ROI within a relatively short time period, depending on usage levels
and price you are currently paying for LN2. Proven technology and innovative product features set F-DGSi apart from their competitors. Using PSA Technology for nitrogen production, F-DGSi gas generators can deliver a much drier and higher purity nitrogen than produced using hollow fi bre mem- branes, which are susceptible to humidity and can deplete over time resulting in costly replacement. The CRYOGEN is produced with helium compressor air cooled or water cooled depending on your needs. F-DGSi generators use touch-screen technology with remote access monitoring, a unique feature not available with other generators in the fi eld. Remote Access Monitoring allows you to access the gener- ator remotely, offering the ability to set parameters, view activities and diagnose faults in the event of a breakdown. This is really useful in remote locations where you do not have a local FSE or when access to labs is restricted. The control system gives the user all the information necessary to ensure an effi cient and consistent supply of liquid nitrogen and nitrogen gas are always available. From the process to fl ow and alarms, including automatic operation, Trend graphs, service alarm and service records page, there is simply no other liquid nitrogen system with this amount of information. CRYOGEN Generators are your reliable and effi cient alternative to conventional liquid nitrogen supplies. Taking away the on-going costs, safety considera- tions of deliveries, transportation of traditional liquid gas supplies.
F-DGSi is a French manufacturer and world leader in the innovation of gas generators (Hydrogen, Air Zero, Nitrogen) and liquid nitrogen generators. The company are meeting the needs of different analytical instruments, such as, LC-MS, GC, GC-MS, cryotherapy and other applications used in laborato- ries around the world. Reliability and a high product quality, combined with French creativity and design, allow you to lower your operating costs, reduce en- vironmental impact and eliminate the inconvenience of bottled gas supply.
The Spotlight could be on you!
Check out our Media Information Pack for further details and send your Press Releases to
pr@intlabmate.com
58930pr@reply-direct.com More information online:
ilmt.co/PL/VEwm
Make your own Liquid Nitrogen, anywhere, anytime!
Simply connect the unit to a power supply and the system is ready to deliver liquid nitrogen cooled to -196°C (-321°F).
Main features:
Flow: 10 to 240 L/day Remote connectivity
Safe, clean, reliable Quick ROI
Easy to use, to service Save space
Scan the QR Code
www.f-dgs.com/cryogen
Contact us today to discover more!
www.f-dgs.com Your gas and liquid generator company
info@f-dgs.com | +33(0) 1 64 98 21 00
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
